Apomorphine and
N-n-propylnorapomorphine (NPA) were compared for their ability to induce stereotyped cage climbing and
hypothermia in mice. Climbing behavior was produced by similar doses of
apomorphine and NPA (0.625-2.5 mg/kg s.c.), whereas NPA was 43 times more potent than
apomorphine in inducing a hypothermic response.
SKF38393 caused a shift to the left in the dose-response curve for NPA-induced climbing, the ED50 changing from 0.98 to 0.014 mg/kg.
SKF38393 had no effect on
apomorphine-induced climbing behaviour. The climbing response produced by
apomorphine was antagonised by both D-1 and D-2 antagonists. Climbing behaviour induced by NPA (2.5 mg/kg) could be antagonised by
SCH23390 but not by
clebopride, however climbing behaviour induced by a low dose of NPA (0.06 mg/kg) plus
SKF38393 could be blocked by both D-1 and D-2 receptor antagonists. The hypothermic responses produced by either
apomorphine or NPA could only be reversed by the selective D-2 antagonist,
clebopride. These results demonstrate that
dopamine agonist-induced stereotyped cage climbing requires both D-1 and D-2 receptor stimulation, whereas the hypothermic response is D-2-mediated. The results also show that it is possible to assess the relative activity of a
dopamine agonist at D-1 or D-2 receptors in vivo by comparing the ability of the compound to induce
hypothermia and climbing behaviour.